Bleeding diathesis: Difference between revisions
No edit summary |
|||
Line 57: | Line 57: | ||
# Acquired Inhibitors of Coagulation Factors | # Acquired Inhibitors of Coagulation Factors | ||
== | == Differentiating Bleeding Disorders from Other Diseases == | ||
Different causes of | Different causes of bleeding disorders can be differentiated based on their clinical manifestation and laboratory findings. | ||
These features have discussed in the below table: | These features have discussed in the below table: | ||
{| | {| | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Subcategory | ||
! colspan="2" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! colspan="2" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History | ||
! colspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical manifestation | ! colspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical manifestation | ||
Line 76: | Line 76: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hematoma | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hematoma | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemarthrosis | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemarthrosis | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Plt | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |BT | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |PT | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |PTT | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |TT | ||
|- | |- | ||
! rowspan=" | ! rowspan="16" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Platelet disorders | ||
! rowspan="7" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Thrombocytopenia]] | ! rowspan="7" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Thrombocytopenia]] | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Infection]]-Induced [[thrombocytopenia]]<span name="harr_c115s002s001s002p001"></span><span name="9100754"></span | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Infection]]-Induced [[thrombocytopenia]]<span name="harr_c115s002s001s002p001"></span><span name="9100754"></span> | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* History of prior infection | * History of prior infection | ||
| align="center" style="background:#F5F5F5;" |+ | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |+ | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |+ | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |+ | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |+ | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |+ | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | ↓ | | align="center" style="background:#F5F5F5;" | ↓ | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
|- | |- | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Medication|Medications]]-Induced [[Thrombocytopenia|thrombocy]]<span name="harr_c115s002s001s003p001"></span><span name="9100757"></span>[[Thrombocytopenia|topenia]] | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Medication|Medications]]-Induced [[Thrombocytopenia|thrombocy]]<span name="harr_c115s002s001s003p001"></span><span name="9100757"></span>[[Thrombocytopenia|topenia]] | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
*History of [[Medication|medications]] such as: | *History of [[Medication|medications]] such as: | ||
Line 112: | Line 112: | ||
** [[Linezolid]] | ** [[Linezolid]] | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |+ | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
Line 119: | Line 119: | ||
| align="center" style="background:#F5F5F5;" | ↓ | | align="center" style="background:#F5F5F5;" | ↓ | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | Most important part of treatment is discontinuing of the medication. | | align="center" style="background:#F5F5F5;" | Most important part of treatment is discontinuing of the medication. | ||
|- | |- | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Heparin-Induced Thrombocytopenia|Heparin-Induced thrombocytopenia]]<span name="harr_c115s002s001s004p001"></span><span name="9100761"></span | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Heparin-Induced Thrombocytopenia|Heparin-Induced thrombocytopenia]]<span name="harr_c115s002s001s004p001"></span><span name="9100761"></span> | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* [[Thrombosis]] | * [[Thrombosis]] | ||
Line 136: | Line 136: | ||
| align="center" style="background:#F5F5F5;" | ↓ | | align="center" style="background:#F5F5F5;" | ↓ | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | For more information click here: [[Heparin-induced thrombocytopenia]]. | | align="center" style="background:#F5F5F5;" | For more information click here: [[Heparin-induced thrombocytopenia]]. | ||
|- | |- | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Idiopathic thrombocytopenic purpura|Immune Thrombocytopenic Purpura]] ([[Idiopathic thrombocytopenic purpura|ITP]])<span name="harr_c115s002s001s005p001"></span><span name="9100771"></span | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Idiopathic thrombocytopenic purpura|Immune Thrombocytopenic Purpura]] ([[Idiopathic thrombocytopenic purpura|ITP]])<span name="harr_c115s002s001s005p001"></span><span name="9100771"></span> | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* History of prior [[infection]] or no history | * History of prior [[infection]] or no history | ||
Line 152: | Line 152: | ||
| align="center" style="background:#F5F5F5;" | ↓ | | align="center" style="background:#F5F5F5;" | ↓ | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
|- | |- | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Inherited [[Thrombocytopenia]]<span name="harr_c115s002s001s006p001"></span><span name="9100783"></span | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Inherited [[Thrombocytopenia]]<span name="harr_c115s002s001s006p001"></span><span name="9100783"></span> | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* Positive family history | * Positive family history | ||
Line 168: | Line 168: | ||
| align="center" style="background:#F5F5F5;" | ↓ | | align="center" style="background:#F5F5F5;" | ↓ | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
|- | |- | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Thrombotic thrombocytopenic purpura|Thrombotic Thrombocytopenic Purpura]] ([[Thrombotic thrombocytopenic purpura|TTP]])<span name="harr_c115s002s002s001p001"></span><span name="9100787"></span | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Thrombotic thrombocytopenic purpura|Thrombotic Thrombocytopenic Purpura]] ([[Thrombotic thrombocytopenic purpura|TTP]])<span name="harr_c115s002s002s001p001"></span><span name="9100787"></span> | ||
| align="left" style="background:#F5F5F5;" | History of: | | align="left" style="background:#F5F5F5;" | History of: | ||
*[[Cancer]] | *[[Cancer]] | ||
Line 190: | Line 190: | ||
| align="center" style="background:#F5F5F5;" | ↓ | | align="center" style="background:#F5F5F5;" | ↓ | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
|- | |- | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Hemolytic-uremic syndrome|Hemolytic Uremic Syndrome]]<span name="harr_c115s002s002s002p001"></span><span name="9100796"></span | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Hemolytic-uremic syndrome|Hemolytic Uremic Syndrome]]<span name="harr_c115s002s002s002p001"></span><span name="9100796"></span> | ||
| align="left" style="background:#F5F5F5;" |History of: | | align="left" style="background:#F5F5F5;" |History of: | ||
* [[Infections]] | * [[Infections]] | ||
Line 212: | Line 212: | ||
| align="center" style="background:#F5F5F5;" | ↓ | | align="center" style="background:#F5F5F5;" | ↓ | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
|- | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Subcategory | |||
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |History | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mucosal bleeding | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Petechia | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ecchymoses | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Menorrhagia | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hematoma | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemarthrosis | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Plt | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |BT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PTT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |TT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Comments | |||
|- | |- | ||
! align="center" style="padding: 5px 5px; background: #DCDCDC;" |Thromobcytosis | ! align="center" style="padding: 5px 5px; background: #DCDCDC;" |Thromobcytosis | ||
Line 235: | Line 251: | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl or ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
|- | |- | ||
Line 255: | Line 271: | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
| align="center" style="background:#F5F5F5;" | Rare | | align="center" style="background:#F5F5F5;" | Rare | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl or ↓ | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* AR inheritance | * AR inheritance | ||
Line 265: | Line 281: | ||
* Diminished for GP 2B-3A on [[Flow cytometry|flow cytometry]] | * Diminished for GP 2B-3A on [[Flow cytometry|flow cytometry]] | ||
|- | |- | ||
! align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Bernard-Soulier syndrome]] | ! align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Bernard-Soulier syndrome]] | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* Positive family history | * Positive family history | ||
Line 274: | Line 290: | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl or ↓ | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* AR inheritance | * AR inheritance | ||
Line 285: | Line 301: | ||
* Ristocetin - no aggregation | * Ristocetin - no aggregation | ||
|- | |- | ||
! align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Wiskott-Aldrich syndrome]] | ! align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Wiskott-Aldrich syndrome]] | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* Positive family history | * Positive family history | ||
Line 294: | Line 310: | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl or ↓ | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* Anti-WASP antibody can be used to detect presence or absence of WAS protein | * Anti-WASP antibody can be used to detect presence or absence of WAS protein | ||
* In Wiskott–Aldrich syndrome, the [[Platelet|platelets]] are small and do not function properly. They are removed by the [[spleen]], which leads to low [[platelet]] counts. | * In Wiskott–Aldrich syndrome, the [[Platelet|platelets]] are small and do not function properly. They are removed by the [[spleen]], which leads to low [[platelet]] counts. | ||
|- | |- | ||
! align="left" style="padding: 5px 5px; background: #DCDCDC;" | ! align="left" style="padding: 5px 5px; background: #DCDCDC;" |Platelet storage pool disorder: | ||
*[[Hermansky-Pudlak syndrome]] | *[[Hermansky-Pudlak syndrome]] | ||
*[[Chediak-Higashi syndrome]] | *[[Chediak-Higashi syndrome]] | ||
*[[Gray platelet syndrome]] | *[[Gray platelet syndrome]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Positive family history | * Positive family history | ||
* [[Hairy cell leukemia]] | * [[Hairy cell leukemia]] | ||
Line 317: | Line 333: | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl or ↓ | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* AD inheritance | * AD inheritance | ||
* | * AbNlities of platelet granule formation | ||
|- | |- | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Acquired Disorders of [[Platelet]] Function<span name="harr_c115s002s004s002p001"></span><span name="9100808"></span> | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Acquired Disorders of [[Platelet]] Function<span name="harr_c115s002s004s002p001"></span><span name="9100808"></span> | ||
| align="left" style="background:#F5F5F5 | | | align="left" style="background:#F5F5F5 " | | ||
* [[Chronic renal failure pathophysiology|Uremia]] | * [[Chronic renal failure pathophysiology|Uremia]] | ||
* [[Cardiopulmonary bypass]] | * [[Cardiopulmonary bypass]] | ||
Line 335: | Line 351: | ||
| align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki> | | align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki> | ||
| align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki> | | align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl or ↓ | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | − | | align="center" style="background:#F5F5F5;" | − | ||
|- | |- | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Von Willebrand disease|Von Willebrand Disease]]<span name="harr_c115s002s005p001"></span><span name="9100810"></span | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Von Willebrand disease|Von Willebrand Disease]]<span name="harr_c115s002s005p001"></span><span name="9100810"></span> | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* Easy bruising | * Easy bruising | ||
Line 356: | Line 372: | ||
| align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki> | | align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki> | ||
| align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki> | | align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | ↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | Nl | ||
| align="center" style="background:#F5F5F5;" | See the table below for the details about different types. | | align="center" style="background:#F5F5F5;" | See the table below for the details about different types. | ||
|- | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Subcategory | |||
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |History | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mucosal bleeding | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Petechia | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ecchymoses | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Menorrhagia | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hematoma | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemarthrosis | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Plt | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |BT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PTT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |TT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Comments | |||
|- | |- | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Vessel wall disorders | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Vessel wall disorders | ||
! | ! align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Metabolism|Metabolic]] and [[Inflammation|Inflammatory]] Disorders | ||
! align="left" style="padding: 5px 5px; background: #DCDCDC;" | | ! colspan="2" align="left" style="padding: 5px 5px; background: #DCDCDC;" | | ||
* Acute febrile illnesses | * Acute febrile illnesses | ||
* [[Cryoglobulinemia|Mixed cryoglobulinemia]] | * [[Cryoglobulinemia|Mixed cryoglobulinemia]] | ||
* [[Monoclonal gammopathy|Monoclonal gammopathies]] | * [[Monoclonal gammopathy|Monoclonal gammopathies]] | ||
* | * [[Rocky Mountain spotted fever]] | ||
* [[Vitamin C]] | * [[Vitamin C deficiency]] | ||
* [[Cushing's syndrome|Cushing’s syndrome]] | * [[Cushing's syndrome|Cushing’s syndrome]] | ||
* Chronic [[glucocorticoid]] therapy | * Chronic [[glucocorticoid]] therapy | ||
* [[Vasculitis]] such as Henoch-Schönlein Purpura | |||
* [[Vasculitis]] such as Henoch-Schönlein | | align="left" style="background:#F5F5F5;" | | ||
| | * History of the underlying disease | ||
* History of the underlying disease | | align="center" style="background:#F5F5F5;" |− | ||
|− | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" |± | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl or ↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | |||
|- | |- | ||
! | ! align="center" style="padding: 5px 5px; background: #DCDCDC;" |Inherited Disorders of the [[Vessel wall|Vessel Wall]] | ||
! align="left" style=" | ! colspan="2" align="left" style="background:#DCDCDC;" | | ||
* [[Marfan's syndrome|Marfan’s syndrome]] | * [[Marfan's syndrome|Marfan’s syndrome]] | ||
* [[Ehlers-Danlos syndrome]] | * [[Ehlers-Danlos syndrome]] | ||
* [[Pseudoxanthoma elasticum]] | * [[Pseudoxanthoma elasticum]] | ||
* [[Hereditary hemorrhagic telangiectasia]] ([[Hereditary hemorrhagic telangiectasia|HHT]], or [[Osler-Weber-Rendu|Osler-Weber-Rendu disease]]) | * [[Hereditary hemorrhagic telangiectasia]] ([[Hereditary hemorrhagic telangiectasia|HHT]], or [[Osler-Weber-Rendu|Osler-Weber-Rendu disease]]) | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Positive family history | * Positive family history | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" |± | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |Nl or ↑ | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
|- | |- | ||
! rowspan=" | ! rowspan="15" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Coagulation factor disorders | ||
! | <ref name="pmid28966616" /> | ||
! align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Fibrinogen]] deficiency | |||
! colspan="2" align="left" style="padding: 5px 5px; background: #DCDCDC;" | | |||
Different types of the [[fibrinogen]] disorders: | |||
* [[Fibrinogen#Congenital afibrinogenemia|Congenital afibrinogenemia]] | * [[Fibrinogen#Congenital afibrinogenemia|Congenital afibrinogenemia]] | ||
* [[Fibrinogen#Congenital hypofibrinogenemia|Congenital hypofibrinogenemia]] | * [[Fibrinogen#Congenital hypofibrinogenemia|Congenital hypofibrinogenemia]] | ||
Line 422: | Line 455: | ||
* [[Fibrinogen#Hereditary fibrinogen A.CE.B1-Chain amyloidosis|Hereditary fibrinogen Aα-Chain amyloidosis]] | * [[Fibrinogen#Hereditary fibrinogen A.CE.B1-Chain amyloidosis|Hereditary fibrinogen Aα-Chain amyloidosis]] | ||
* [[Fibrinogen#Acquired dysfibrinogenemia|Acquired dysfibrinogenemia]] | * [[Fibrinogen#Acquired dysfibrinogenemia|Acquired dysfibrinogenemia]] | ||
| align="left" style="background:#F5F5F5;" | | |||
| | |||
* [[Epistaxis]] | * [[Epistaxis]] | ||
* Easy [[Bruise|bruising]] | * Easy [[Bruise|bruising]] | ||
Line 432: | Line 463: | ||
* [[Bleeding]] from the [[umbilical cord]] stump after birth | * [[Bleeding]] from the [[umbilical cord]] stump after birth | ||
* Bleeding after [[dental surgery]] or tooth extraction | * Bleeding after [[dental surgery]] or tooth extraction | ||
* | * AbNl bleeding during or after injury, surgery, or childbirth | ||
* [[Gastrointestinal tract|Gastrointestinal]] [[hemorrhage]] | * [[Gastrointestinal tract|Gastrointestinal]] [[hemorrhage]] | ||
* [[Cerebral hemorrhage]] | * [[Cerebral hemorrhage]] | ||
* [[Thrombosis]] | * [[Thrombosis]] | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| + | | align="center" style="background:#F5F5F5;" | + | ||
| + | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" |± | ||
| + | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Impaired fibrin cross linking or clot dissolution | * Impaired fibrin cross-linking or clot dissolution | ||
* Mild or severe bleeding idepend on levels of functional fibrinogen | |||
* | * Variable age of onset | ||
|- | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Subcategory | |||
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |History | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mucosal bleeding | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Petechia | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ecchymoses | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Menorrhagia | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hematoma | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemarthrosis | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Plt | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |BT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PTT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |TT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Comments | |||
|- | |- | ||
! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Prothrombin deficiency]] | ! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Prothrombin deficiency]] | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* [[Epistaxis]] | * [[Epistaxis]] | ||
* Soft-tissue hemorrhage | * Soft-tissue hemorrhage | ||
Line 463: | Line 508: | ||
* [[Hemarthrosis]] | * [[Hemarthrosis]] | ||
* [[Intracranial hemorrhage|Intracranial]] bleeding | * [[Intracranial hemorrhage|Intracranial]] bleeding | ||
| | | align="center" style="background:#F5F5F5;" | − | ||
| | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" | Nl | ||
| | | align="center" style="background:#F5F5F5;" | Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" | ↑ | ||
| | | align="center" style="background:#F5F5F5;" | − | ||
|- | |- | ||
! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor V deficiency]] | ! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor V deficiency]] | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Excessive bruising with minor injuries | * Excessive bruising with minor injuries | ||
* [[Epistaxis]] | * [[Epistaxis]] | ||
Line 484: | Line 529: | ||
* [[Intracerebral hemorrhage|Intracerebral hemorrhages]] | * [[Intracerebral hemorrhage|Intracerebral hemorrhages]] | ||
* [[Pulmonary hemorrhage]] | * [[Pulmonary hemorrhage]] | ||
| | | align="center" style="background:#F5F5F5;" | − | ||
| | | align="center" style="background:#F5F5F5;" | − | ||
| | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" | + | ||
| + | | align="center" style="background:#F5F5F5;" | + | ||
| + | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
|The severity of bleeding | | align="center" style="background:#F5F5F5;" | | ||
* The severity of bleeding related to the degree of factor V deficiency | |||
|- | |- | ||
! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor VII deficiency]] | ! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor VII deficiency]] | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Easy [[Bruise|bruising]] | * Easy [[Bruise|bruising]] | ||
* Mucosal bleeding | * Mucosal bleeding | ||
Line 505: | Line 551: | ||
* Soft tissue hematomas | * Soft tissue hematomas | ||
* [[Thrombosis]] | * [[Thrombosis]] | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | + | ||
| + | | align="center" style="background:#F5F5F5;" | + | ||
| + | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" | | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
|Thrombosis | | align="left" style="background:#F5F5F5;" | | ||
* Thrombosis in inherited factor VII deficiency | |||
* Treatment with the administration of factor VII replacement therapy | |||
|- | |- | ||
! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor X deficiency]] | ! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor X deficiency]] | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Prolonged bleeding following circumcision | * Prolonged bleeding following circumcision | ||
* Easy [[Bruise|bruising]] | * Easy [[Bruise|bruising]] | ||
* [[Hematuria]] | * [[Hematuria]] | ||
Line 531: | Line 578: | ||
* Intracranial bleeding | * Intracranial bleeding | ||
* Hemarthroses | * Hemarthroses | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" | + | ||
| + | | align="center" style="background:#F5F5F5;" | + | ||
| + | | align="center" style="background:#F5F5F5;" | + | ||
| + | | align="center" style="background:#F5F5F5;" | + | ||
| + | | align="center" style="background:#F5F5F5;" | + | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
|- | |- | ||
! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor XII|Factor XII deficiency]] | ! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor XII|Factor XII deficiency]] | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* | * Asymptomatic | ||
* Recurrent miscarriages | * Recurrent miscarriages | ||
* Painful leg ulcers | * Painful leg ulcers | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" | | ||
|- | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Subcategory | |||
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |History | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mucosal bleeding | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Petechia | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ecchymoses | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Menorrhagia | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hematoma | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemarthrosis | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Plt | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |BT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PTT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |TT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Comments | |||
|- | |- | ||
! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[High-molecular-weight kininogen|High molecular weight kininogen (HMWK)]] deficiency | ! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[High-molecular-weight kininogen|High molecular weight kininogen (HMWK)]] deficiency | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* | * Positive family history of bleeding | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Prekallikrein]] deficiency | ! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Prekallikrein]] deficiency | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* | * Positive family history of bleeding | ||
| | | align="center" style="background:#F5F5F5;" | | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! | ! rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor XIII deficiency]] | ||
! style="padding: 5px 5px; background: #DCDCDC;" | | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" | | ||
* Sub unit A mutation disease (more common) | * Sub unit A mutation disease (more common) | ||
* Sub unit B mutation disease | * Sub unit B mutation disease | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* | * Positive family history of bleeding | ||
| | | align="center" style="background:#F5F5F5;" |± | ||
| | | align="center" style="background:#F5F5F5;" |± | ||
| | | align="center" style="background:#F5F5F5;" |± | ||
| | | align="center" style="background:#F5F5F5;" |± | ||
| | | align="center" style="background:#F5F5F5;" |± | ||
| | | align="center" style="background:#F5F5F5;" |± | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl or ↑ | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Impaired fibrin cross linking or clot dissolution | * Impaired fibrin cross-linking or clot dissolution | ||
* The severity of factor XIII deficiency bleeds can be different in different patients | * The severity of factor XIII deficiency bleeds can be different in different patients | ||
|- | |- | ||
! rowspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Hemophilia]] | ! rowspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Hemophilia]] | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type A deficiency | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type A deficiency | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Eeasy [[Bruise|bruising]] | * Eeasy [[Bruise|bruising]] | ||
* Inadequate clotting in [[trauma]] or mild injury | * Inadequate clotting in [[trauma]] or mild injury | ||
Line 625: | Line 687: | ||
* [[Epistaxis]] | * [[Epistaxis]] | ||
* [[Gingival bleeding]] | * [[Gingival bleeding]] | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
|- | |- | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type B deficiency | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type B deficiency | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Neonatal bleeding | * Neonatal bleeding | ||
* Trauma-related soft | * Trauma-related soft tissue hemorrhage | ||
* [[Hemarthrosis]] | * [[Hemarthrosis]] | ||
* [[Hematoma|Hematomas]] | * [[Hematoma|Hematomas]] | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
|- | |- | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type C deficiency | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type C deficiency | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* | * Positive family history | ||
* Bleeding after surgery or injury | * Bleeding after surgery or injury | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
|Rare | | align="center" style="background:#F5F5F5;" |Rare | ||
|Rare | | align="center" style="background:#F5F5F5;" |Rare | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| - | | align="center" style="background:#F5F5F5;" |− | ||
|- | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Subcategory | |||
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |History | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mucosal bleeding | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Petechia | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ecchymoses | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Menorrhagia | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hematoma | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemarthrosis | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Plt | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |BT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PTT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |TT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Comments | |||
|- | |- | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rare diseases | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rare diseases | ||
! colspan=" | ! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Disseminated intravascular coagulation|Disseminated Intravascular Coagulation]] | ||
| align="left" style="background:#F5F5F5;" | | |||
* [[Trauma]] | * [[Trauma]] | ||
* Burn | * [[Burn]] | ||
* [[Crush injury]] | * [[Crush injury]] | ||
* [[Sepsis]] | * [[Sepsis]] | ||
Line 684: | Line 762: | ||
* Obstetric complication: abruption, amniotic fluid embolism | * Obstetric complication: abruption, amniotic fluid embolism | ||
* [[Hemolytic anemia]] | * [[Hemolytic anemia]] | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
|↓ | | align="center" style="background:#F5F5F5;" |↓ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
| | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" |− | ||
|- | |- | ||
! colspan=" | ! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Vitamin K Deficiency]] | ||
| align="left" style="background:#F5F5F5;" | | |||
* Bleeding after trauma | * Bleeding after trauma | ||
* [[Epistaxis]] | * [[Epistaxis]] | ||
Line 708: | Line 786: | ||
* Oozing from venipuncture sites | * Oozing from venipuncture sites | ||
* Easy [[Bruise|bruisability]] | * Easy [[Bruise|bruisability]] | ||
| align="center" style="background:#F5F5F5;" |+ | |||
| align="center" style="background:#F5F5F5;" |− | |||
| align="center" style="background:#F5F5F5;" |+ | |||
| align="center" style="background:#F5F5F5;" |+ | |||
| align="center" style="background:#F5F5F5;" |+ | |||
| align="center" style="background:#F5F5F5;" |+ | |||
| align="center" style="background:#F5F5F5;" |Nl | |||
| align="center" style="background:#F5F5F5;" |↑ | |||
| align="center" style="background:#F5F5F5;" |↑ | |||
| align="center" style="background:#F5F5F5;" |Nl or mildly prolonged | |||
| align="center" style="background:#F5F5F5;" |Nl | |||
| align="center" style="background:#F5F5F5;" |− | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | ↑ | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
|} | |} | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 17:20, 19 October 2018
Bleeding diathesis main page |
|
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2], Nazia Fuad M.D., Sogand Goudarzi, MD [3]
Synonyms and keywords: Hypocoagulopathy; Bleeding disorders.
Overview
Bleeding diathesis is susceptibility to bleed due to coagulopathy disorders or platelets disorders. These diseases can occur due to a disorder of homeostasis, localized process (tissue injury), or medications. Bleeding diathesis can be resulted from vessel wall injury, platelet disorders, and coagulation factor disorders. Clinical manifestation of bleeding disorders can have a wide range of symptoms from asymptomatic to symptomatic massive and life threatening bleeding. Platelet disorders mostly have skin manifestations such as petechiae, and ecchymoses. In order to find the cause of hypo-coagulopathy; there are established laboratory tests, such as peripheral blood smear, platelet count and platelet function analysis, coagulation factor deficiencies and inhibitors, fibrinolysis tests (eg. D-dimer level), bleeding time (BT), prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), and reptilase time. In the case of any abnormal bleeding, first line of screening tests are CBC, PT, PTT, BT, and TT.[1]
Classification
Disorders of hemostasis can be classified into two main categories: platelet disorders, and disorders of coagulation. Each category can be further classified as bellow:
Abnormal hemostasis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
•Patient history-sign & symptom: Deep soft tissue bleeding Mucocutaneus bleeding •Screen test CBBC-plt-PT&PTT-BT-TT | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hx of deep soft tissue bleeding | Hx of mucocotaneus bleeding | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Coagulopathy | Plt disorder | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Family history | Normal plt count | Low plt count | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(+) •Inherited coagulpathy | (-) •Aquired coagulopathy | Functional Plt disorder | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
↑Plt •Hemophillia •VWD •FactorVIII or IX deficiency | ↑PT • Factor VII deficiensy | ↑PT&↑PTT •Fibrinogen deficiency •FactorII deficiency •FactorV deficiency •FactorX deficiency | ↑PTT •Factor inhibitor •Anti phospholipid A6syndrome | ↑PT •Factor inhibitor •VitK deficiency •Liver disease | ↑PT&↑PTT •Factor inhibit •DIC •Liver failure •late stage of VitK deficincy | ↑Afibrinogenia •Heparin inhibitor •Direct thrombin inhibitor | Abnormal solobity •FactorXIII deficincy •Cross-linkin inhibitor | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Not corrected with mixing with NL plasma | HX(+) | HX(-) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
•Factor inhibitors •Lupus anti coagulant •DIC •Heparin or direct thrombin inhibitors | Congenital | Acquired | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Platelet disorders:
- Thrombocytopenia: platelet count less than 150,000 per mm3
- Thromobcytosis: platelet count more than 450,000 per mm3
- Qualitative Disorders of Platelet function such as Von Willebrand Disease, inherited or acquired functional disorders.
Coagulation disorders
- Vessel wall disorders: Endothelial cells are lining entire vessel walls all over the body. Endothelium is an active layer responsible for inflammatory responses, angiogenesis and blood cell interactions. Endothelial cells have a very important role in hemostasis and they are regulating blood fluidity by the balance of antithrombotic/prothrombotic and vasodilatory/vasoconstrictor effects.
- Metabolic and Inflammatory Disorders
- Inherited Disorders of the Vessel Wall
- Coagulation factor disorders:
- Fibrinogen deficiency
- Prothrombin deficiency
- Factor V deficiency
- Factor VII deficiency
- Factor X deficiency
- Factor XII deficiency
- HK deficiency
- Prekallikrein deficiency
- Factor XIII deficiency
- Hemophilia
- Disseminated Intravascular Coagulation
- Vitamin K Deficiency
- Coagulation Disorders Associated with Liver Failure
- Acquired Inhibitors of Coagulation Factors
Differentiating Bleeding Disorders from Other Diseases
Different causes of bleeding disorders can be differentiated based on their clinical manifestation and laboratory findings.
These features have discussed in the below table:
Category | Subcategory | Disease | History | Clinical manifestation | Laboratory testing | Comments | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | ||||||
Platelet disorders | Thrombocytopenia | Infection-Induced thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |
Medications-Induced thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | Most important part of treatment is discontinuing of the medication. | |||
Heparin-Induced thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | ↑ | For more information click here: Heparin-induced thrombocytopenia. | |||
Immune Thrombocytopenic Purpura (ITP) |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Inherited Thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Thrombotic Thrombocytopenic Purpura (TTP) | History of:
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Hemolytic Uremic Syndrome | History of: | + | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Thromobcytosis | Iron deficiency anemia
Inflammatory diseases |
− | − | − | − | ± | ± | ↑ | Nl or ↑ | Nl | Nl | Nl | − | |||
Qualitative Disorders of Platelet Function | Inherited Disorders of Platelet Function | Glanzmann’s thrombasthenia |
|
+ | + | + | + | − | Rare | Nl or ↓ | ↑ | Nl | Nl | Nl |
| |
Bernard-Soulier syndrome |
|
+ | + | + | + | − | − | Nl or ↓ | ↑ | Nl | Nl | Nl |
| |||
Wiskott-Aldrich syndrome |
|
+ | + | + | + | − | − | Nl or ↓ | ↑ | Nl | Nl | Nl | ||||
Platelet storage pool disorder: |
|
+ | + | + | + | − | − | Nl or ↓ | ↑ | Nl | Nl | Nl |
| |||
Acquired Disorders of Platelet Function |
|
+ | + | + | + | ± | ± | Nl or ↓ | ↑ | Nl | Nl | Nl | − | |||
Von Willebrand Disease |
|
+ | + | + | + | ± | ± | ↑ | Nl | ↑ | ↑ | Nl | See the table below for the details about different types. | |||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Vessel wall disorders | Metabolic and Inflammatory Disorders |
|
|
− | + | + | ± | − | − | Nl | Nl or ↑ | Nl | Nl | Nl | − | |
Inherited Disorders of the Vessel Wall |
|
− | + | + | ± | − | − | Nl | Nl or ↑ | Nl | Nl | Nl | − | |||
Coagulation factor disorders | Fibrinogen deficiency |
Different types of the fibrinogen disorders: |
|
− | − | + | + | ± | + | Nl | ↑ | ↑ | ↑ | ↑ |
| |
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Prothrombin deficiency |
|
− | + | + | + | + | + | Nl | Nl | ↑ | ↑ | ↑ | − | |||
Factor V deficiency |
|
− | − | + | + | + | + | Nl | ↑ | ↑ | ↑ | Nl |
| |||
Factor VII deficiency |
|
+ | + | + | Nl | ↑ | Nl | Nl |
| |||||||
Factor X deficiency |
|
+ | + | + | + | + | Nl | Nl | ↑ | ↑ | Nl | − | ||||
Factor XII deficiency |
|
− | − | − | − | − | Nl | Nl | Nl | ↑ | Nl | |||||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
High molecular weight kininogen (HMWK) deficiency |
|
− | − | − | − | − | Nl | Nl | Nl | ↑ | Nl | |||||
Prekallikrein deficiency |
|
− | − | − | − | − | Nl | Nl | Nl | ↑ | Nl | |||||
Factor XIII deficiency |
|
|
± | ± | ± | ± | ± | ± | Nl | Nl | Nl or ↑ | Nl | Nl |
| ||
Hemophilia | Type A deficiency |
|
− | − | − | + | + | + | Nl | Nl | Nl | ↑ | Nl | − | ||
Type B deficiency |
|
− | − | − | + | + | + | Nl | Nl | Nl | ↑ | Nl | − | |||
Type C deficiency |
|
− | − | − | + | Rare | Rare | Nl | Nl | Nl | ↑ | Nl | − | |||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Rare diseases | Disseminated Intravascular Coagulation |
|
+ | + | + | + | + | + | ↓ | ↑ | ↑ | ↑ | Nl | − | ||
Vitamin K Deficiency |
|
+ | − | + | + | + | + | Nl | ↑ | ↑ | Nl or mildly prolonged | Nl | − |